Drug intelligence / Profile preview

mesenchymal stromal cell extracellular vesicles

Development stage
Preclinical
Lead developer
Sartorius
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intravenous, Topical
01

Overview

Mesenchymal stromal cell extracellular vesicles (MSC-EVs) are nano-sized, membrane-bound particles secreted by mesenchymal stromal cells (MSCs) that encapsulate a diverse cargo of proteins, lipids, and nucleic acids (such as microRNAs). They function as critical mediators of intercellular communication, recapitulating many of the therapeutic paracrine effects of their parent cells. MSC-EVs are being developed as a cell-free alternative to MSC therapy, offering potential advantages in terms of safety, reduced immunogenicity, and manufacturing scalability. They exhibit potent immunomodulatory, anti-inflammatory, and regenerative properties, making them candidates for treating a wide range of conditions including inflammatory diseases, autoimmune disorders, and tissue injuries. Current research, such as that conducted by Sartorius, focuses on optimizing scalable downstream processing (DSP) using bioreactors and chromatography to produce high-purity EV products by depleting non-vesicular extracellular particles (NVEPs).

Other names
MSC-EVsmesenchymal stem cell-derived extracellular vesiclesMSC-derived exosomesmesenchymal stromal cell-derived extracellular vesicles

Beyond the preview

Go deeper on mesenchymal stromal cell extracellular vesicles.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mesenchymal stromal cell extracellular vesicles.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call